Tag

Variant Of Interest

All articles tagged with #variant of interest

health2 years ago

Rapid spread of COVID subvariant JN.1 threatens holiday travel season

Health officials are warning about the rapid spread of the COVID subvariant JN.1, which has become the fastest-growing strain in the US. While studies show that it is not more severe, JN.1 has a mutation that makes it more transmissible among unvaccinated individuals. The World Health Organization has classified it as a variant of interest. Hospitalizations for COVID, influenza, and RSV have been increasing, with experts emphasizing the importance of vaccination. JN.1 currently accounts for 4% of reported variants in Ohio and is expected to become the dominant variant in the Midwest. Travelers are advised to take precautions, such as getting tested before visiting elderly or immunocompromised individuals.

health2 years ago

The Rapid Spread of COVID Variant JN.1: What You Should Know

The World Health Organization has designated JN.1, an Omicron offshoot with an additional major mutation, as a "variant of interest." JN.1 is causing a surge in COVID wastewater levels in some countries, surpassing even the Omicron spike of early 2022. It is still unclear if JN.1 has different symptoms compared to other Omicron variants or if it is more dangerous. COVID vaccines are believed to provide good protection against JN.1, and experts recommend wearing masks and taking reasonable precautions. The antiviral drug Paxlovid is effective against JN.1, but it is important to complete the full course of treatment. At-home COVID tests still work with JN.1, but accuracy can vary. The designation of JN.1 as a variant of interest calls for increased monitoring and sequencing by health authorities. JN.1 is spreading rapidly and outcompeting other variants worldwide, contributing to record levels of COVID spread in countries like Germany, the Netherlands, and Denmark.

health2 years ago

"World Health Organization designates JN.1 COVID strain as a 'variant of interest'"

The World Health Organization (WHO) has classified the new COVID-19 variant JN.1 as a "variant of interest" due to its rapid spread globally. While JN.1 has not been found to cause different or more severe symptoms compared to previous variants, its mutations suggest an advantage in evading immune defenses. The CDC has not yet classified JN.1 as a variant of interest in the United States. Current vaccines are expected to provide protection against JN.1, although early studies indicate lower neutralization of the variant by antibodies. JN.1 is projected to become the dominant variant in the U.S., with estimates suggesting it already accounts for over 20% of cases nationwide.

health2 years ago

WHO Identifies JN.1 as "Variant of Interest" Amid Rapid Spread of New Covid Strain

The World Health Organization (WHO) has classified the JN.1 coronavirus strain as a "variant of interest," but stated that it poses a low risk to public health. JN.1, which was first detected in the US in September, is a subvariant of the parent lineage BA.2.86. Current vaccines are still effective against JN.1 and other circulating variants of the COVID-19 virus. The US Centers for Disease Control and Prevention (CDC) reported that JN.1 accounts for 15% to 29% of cases in the US, but there is no evidence of increased risk compared to other variants. China has also detected seven infections of the JN.1 subvariant.

health2 years ago

Rapid Testing Urged as New COVID-19 Variant Surfaces

The World Health Organization (WHO) has identified a new variant of interest called EG5, which is a mutation of the Omicron variant. EG5 has been found in 51 countries and is similar in symptoms to Omicron. However, the WHO warns that the actual spread of EG5 may be more widespread than reported due to limited testing. The variant is highly transmissible and not as seasonal as previous variants. The WHO urges countries to maintain surveillance measures and increase testing to track the spread of the new variant.

health2 years ago

WHO elevates Arcturus to 'variant of interest' amidst global concern.

The World Health Organization has designated the new COVID-19 strain XBB.1.16, also known as "Arcturus," as a "variant of interest." The strain is a sublineage of Omicron and is currently surging in India, where it is the dominant strain. Despite its tendency to evade immunity, the variant's overall risk is low since it doesn't seem to be causing more severe symptoms. WHO recommends that countries collaborate to share information about Arcturus and conduct tests to see how well their population's immunity can defend against it.